PureTech Health-backed neuropsychiatric drug developer Karuna Therapeutics raised $89.2m in an upsized offering that followed $123m in venture capital.

Spinal cord stimulation device manufacturer Saluda Medical won the support of Boston Scientific for a round that took its total funding past $125m.

Johnson & Johnson has reinvested in the microbiome health management app developer, which has now secured $48m in total.

The South Africa-based healthcare provider has teamed up with Founders Factory Africa to back healthtech startups based on the African continent.

Sanofi, Kaiser Permanente, Providence Health & Services and Cigna all chipped in to help bring digital behavioural treatment developer Omada's total funding to $200m.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

AIG scored an exit as genetic disease and cancer drug developer BridgeBio Pharma floated above its range while increasing the number of shares in its IPO.

Morphic began trading on the Nasdaq Global Market yesterday after issuing 6 million shares priced at $15 each, providing exits to AbbVie, GSK, Novo, Pfizer, Schrödinger and ShangPharma.

University of the Balearic Islands spinout Sanifit has raised $62.8m in a series D round backed by existing backer Lundbeckfonden Ventures to bring its overall financing to $149m.